Pharmafile Logo

FIECON

We are global health economics consultancy, committed to launching products that make a difference in people’s lives. We work across a product’s lifecycle, supporting biotech, pharmaceutical, and medical technology companies.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Fiecon, 3 College Yard, Lower Dagnall Street, St Albans, Hertfordshire, AL3 4PA, United Kingdom
01727 225601

 Latest Content from PMHub 

So, you can deliver excellent outcomes & meaningful impact at low cost

Press Releases | July 25, 2023 | Fox&Cat

Under the tree: an example of behaviour-change in mental health by fox&cat.

The Most Important Person in the Room—A Look at Patient -Centricity at EHA

Across all of healthcare, a greater focus is being placed on patient centricity in order to improve outcomes and enhance patients’ quality of life. Although patient centricity is necessary in...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

CHASE MedTech Outsourcing Solutions

Videos and Podcasts | July 19, 2023 | CHASE

Are you looking for a fast, flexible and affordable solution to your MedTech sales team? Get in touch today to find out how we can help https://lnkd.in/enFTdm6R

CHASE Nurses

Videos and Podcasts | July 19, 2023 | CHASE

Are you currently looking for a new nursing role? Want a work-life balance and continuous learning and development? Check out our exciting nursing roles here: https://lnkd.in/eZVGM7N3Talk to our colleague Victoria Henderson today...

Case study: How segmentation of treaters guided a novel product launch in the allergy space

Find out how we helped our client to obtain an intuitive and actionable segmentation in order to drive market shaping activities ahead of their product launch aimed at the treatment...

Medscape Medical Affairs celebrate a double win at the Communiqué Awards 2023

Medscape Medical Affairs celebrates a remarkable achievement with a double win at the prestigious Communiqué Awards 2023.

The 7 truths behind successful Healthcare influencer engagement programmes

Pharma companies need to be engaging DOLs in the same way as Key Opinion Leaders (KOLs). But how can companies ensure best practice DOL engagement? Here are Say’s recommended critical...

Mobilizing Agitation Detection in Children with ADHD

Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...

Article: War in the Blood – The battle takes shape in the burgeoning European oncology CAR-T market access space

Tania Rodrigues investigates the market access and commercialization potential for manufacturers of CAR-T therapies in the latest issue of pharmaphorum's Deep Dive.